Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial
Titel:
Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial
Auteur:
Nachman, Sharon Alvero, Carmelita Teppler, Hedy Homony, Brenda Rodgers, Anthony J Graham, Bobbie L Fenton, Terence Frenkel, Lisa M Browning, Renee S Hazra, Rohan Wiznia, Andrew A